Study | Variables | Score ranges |
---|---|---|
IABP shock II risk score [68] | 6 indices: ①Age > 73 years (1 pt) ② History of stroke (2 pt) ③ BS > 10.6 mmol/L (191 mg/dL) (1 pt) ④ Cre > 132.6 μmol/L (1.5 mg/dL) (1 pt) ⑤ Arterial lac > 5 mmol/L (2 pt) ⑥ TIMI flow grade < 3 after PCI (2 pt) | 30-day mortality risk Low (0–2) (24%) Intermediate (3–4) (49%) High (5–9) (77%) |
SAVE score [69] | 7 indices: ①Etiology: myocarditis (3 pt), refractory VT/VF (2 pt), post heart/lung transplantation (3 pt), congenital heart disease (− 3 pt) ② Age : 18–38 yr (7 pt), 39–52 yr (4 pt), 53–62 yr (3 pt), ≥ 63yr (0 pt) ③ Weight : < 65kg (1 pt), 65–89 kg (2 pt), ≥ 90 kg (0 pt) ④ Cardiac: pre-ECMO cardiac arrest (− 2 pt), diastolic BP before ECMO ≥ 40 mmHg (3 pt), pulse pressure before ECMO ≤ 20 mmHg (− 2 pt) ⑤ Respiratory: peak inspiratory pressure ≤ 20 cmH2O (3 pt), duration of intubation pre ECMO; ≤ 10 h (0 pt), 11–29 h (−2 pt), ≥ 30h (− 4 pt) ⑥ Renal dysfunction : acute renal failure (− 3 pt), chronic renal failure (− 6 pt), HCO3 pre ECMO ≤ 15 mmol/L (− 3 pt) ⑦ Other organ failure: liver failure (− 3 pt), CNS dysfunction (− 3 pt) | In-hospital survival rate Risk I >5 (75%) Risk II 1 to 5 (58%) Risk III − 4 to 0 (42%) Risk IV − 9 to − 5 (30%) Risk V ≤ − 10 ( (18%) |
ENCOURAGE mortality risk score [70] | 7 indices: ①Age >60 (5 pt) ② Gender: female (7 pt) ③ BMI > 25 kg/m2 (6 pt) ④ GCS < 6 (6 pt) ⑤ Cre >150 μmol/L or 1.7 mg/dL (5 pt) ⑥ Lac : < 2 mmol/L (0 pt), 2–8 mmol/L (8 pt), > 8 mmol/L (11 pt) ⑦ Reduced prothrombin activity < 50% (5 pt) | 1 month survival rate 0–12 (92%) 13–18 (70%) 19–22 (35%) 23–27 (28%) ≥ 28 (17%) |